Composition:
Active substance: Letrozole
Excipients: Lactose monohydrate (Spray Dried), Microcrystalline Cellulose, Maize Starch, Sodium Starch glycolate (Type A), Silica, Colloidal anhydrous Magnesium Stearate.
coating: Opadry yellow 02B38014,Titanium dioxide E171, Yellow Iron Oxide E172, Macrogol, Red Iron Oxide E172, Talc, Hypromellose 5cP .
Indications:
First line treatment in post-menopausal women with advanced hormone-dependent breast cancer.
is is recommended in advanced breast cancer treatment in women with natural or artificially-induced menopause after a disease recurrence or evolution, previously subject to anti-estrogens treatment.
Efficacy in patients with negative estrogens receptors has not been evidenced.

Composition :
Each tablet contains 25 mg of exemestane as the active ingredient.
Indication :
Exemestane/Genepharm is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer, following 2 – 3 years of initial adjuvant tamoxifen therapy.
Exemestane/Genepharm is indicated for the treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy. Efficacy has not been demonstrated in patients with oestrogen receptor negative status.

Composition :Active substance: Bicalutamide
Excipients: Lactose monohydrate, Povidone K-25, Sodium starch glycollate, Magnesium stearate, Hypromellose, Titanium dioxide, Propylene glycol.
Indication : Bicamide is a non-steroidal anti-androgen. It is indicated for the treatment of metastatic carcinoma of prostate.

Composition: Active substance: Carboplatin. Excipients: Water for injections

Therapeutic indications: Carboplatin is indicated for the treatment of the following carcinoma:

• Advanced ovarian carcinoma
• Lung, small cell carcinoma
• Lung, non-small carcinoma
• Head and neck carcinoma
• Testicular carcinoma (in combination with other cytostatics)

Qualitative and Quantitative composition in active ingredients:
Doxorubicin Hydrochloride 10mg/5ml VIAL, 50mg/25m1 VIAL, 20mg/10ml VIAL, 100mg/50m1 VIAL

Indication :
Doxorubicin has produced significant therapeutic response in a number of solid tumors and haematologic malignancies, and is commonly used in the treatment of the following neoplastic diseases:

• breast cancer • lung cancer • ovarian cancer • transitional cell bladder cancer • neuroblastoma • Wilm's tumor • soft tissue sarcomas • osteosarcoma • acute lymphocytic - lymphoblastic leukemia
• acutemyelogenous leukemia • non-Hodgkin's lymphomas • Hodgkin's disease • thyroid cancer

Qualitative and Quantitative composition in active ingredients:
Doxorubicin Hydrochloride 10mg/5ml VIAL, 50mg/25m1 VIAL, 20mg/10ml VIAL, 100mg/50m1 VIAL

Indication :
Doxorubicin has produced significant therapeutic response in a number of solid tumors and haematologic malignancies, and is commonly used in the treatment of the following neoplastic diseases:

• breast cancer • lung cancer • ovarian cancer • transitional cell bladder cancer • neuroblastoma • Wilm's tumor • soft tissue sarcomas • osteosarcoma • acute lymphocytic - lymphoblastic leukemia
• acutemyelogenous leukemia • non-Hodgkin's lymphomas • Hodgkin's disease • thyroid cancer

The active substance in Zoledronic Acid LOGENEX 4 mg/5 ml is zoledronic acid, which belongs to a group of substances called bisphosphonates. Zoledronic acid works by attaching itself to the bone and slowing down the rate of bone change. It is used:
• To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone).
• To reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumour. Tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumour-induced hypercalcaemia (TIH).

Geneplatin contains:
The active substance is oxaliplatin.
Each vial contains 50 mg or 100 mg of oxaliplatin.
The other ingredient is water for injection and Nitrogen.
The active ingredient of Geneplatin is oxaliplatin.
Geneplatin is used to treat cancer of the large bowel (treatment of stage III colon cancer after complete resection of primary tumour, metastatic cancer of colon and rectum).
Geneplatin is used in combination with other anticancer medicines called 5 fluorouracil and folinic acid.
Geneplatin is an antineoplastic or anticancer drug and contains platinum.

Geneplatin contains:
The active substance is oxaliplatin.
Each vial contains 50 mg or 100 mg of oxaliplatin.
The other ingredient is water for injection and Nitrogen.

The active ingredient of Geneplatin is oxaliplatin.
Geneplatin is used to treat cancer of the large bowel (treatment of stage III colon cancer after complete resection of primary tumour, metastatic cancer of colon and rectum).
Geneplatin is used in combination with other anticancer medicines called 5 fluorouracil and folinic acid.
Geneplatin is an antineoplastic or anticancer drug and contains platinum.

Quetiapine/Genepharm contains a substance called quetiapine. This belongs to a group of medicines called antipsychotics.
Quetiapine/Genepharm can be used to treat several illnesses, such as:
• Bipolar depression: where you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose your appetite or can’t sleep.
• Mania: where you may feel very excited, elated, agitated, enthusiastic or hyperactive or have poor judgment including being aggressive or disruptive.
• Schizophrenia: where you may hear or feel things that are not there, believe things that are not true or feel unusually suspicious, anxious, confused, guilty, tense or depressed.
Your doctor may continue to prescribe Quetiapine/Genepharm even when you are feeling better.

Quetiapine/Genepharm contains a substance called quetiapine. This belongs to a group of medicines called antipsychotics.
Quetiapine/Genepharm can be used to treat several illnesses, such as:
• Bipolar depression: where you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose your appetite or can’t sleep.
• Mania: where you may feel very excited, elated, agitated, enthusiastic or hyperactive or have poor judgment including being aggressive or disruptive.
• Schizophrenia: where you may hear or feel things that are not there, believe things that are not true or feel unusually suspicious, anxious, confused, guilty, tense or depressed.
Your doctor may continue to prescribe Quetiapine/Genepharm even when you are feeling better.

Quetiapine/Genepharm contains a substance called quetiapine. This belongs to a group of medicines called antipsychotics.
Quetiapine/Genepharm can be used to treat several illnesses, such as:
• Bipolar depression: where you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose your appetite or can’t sleep.
• Mania: where you may feel very excited, elated, agitated, enthusiastic or hyperactive or have poor judgment including being aggressive or disruptive.
• Schizophrenia: where you may hear or feel things that are not there, believe things that are not true or feel unusually suspicious, anxious, confused, guilty, tense or depressed.
Your doctor may continue to prescribe Quetiapine/Genepharm even when you are feeling better.

Quetiapine/Genepharm contains a substance called quetiapine. This belongs to a group of medicines called antipsychotics.
Quetiapine/Genepharm can be used to treat several illnesses, such as:

• Bipolar depression: where you feel sad. You may find that you feel depressed, feel guilty, lack energy, lose your appetite or can’t sleep.
• Mania: where you may feel very excited, elated, agitated, enthusiastic or hyperactive or have poor judgment including being aggressive or disruptive.
• Schizophrenia: where you may hear or feel things that are not there, believe things that are not true or feel unusually suspicious, anxious, confused, guilty, tense or depressed.
Your doctor may continue to prescribe Quetiapine/Genepharm even when you are feeling better.

Composition
Polacrilin Potassium, Microcrystalline cellulose, Lactose monohydrate (Spray Dried), Monosodium citrate anhydrous, Aspartame (E951), Croscarmellose sodium, Silica colloidal anhydrous, Magnesium Stearate, Hydrochloric acid for pH adjustments and purified water.
Indications
Donepezil/Genepharm (donepezil hydrochloride) belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil increases the levels of a substance (acetylcholine) in the brain involved in memory function by slowing down the breakdown of acetylcholine.
It is used to treat the symptoms of dementia in people diagnosed as having mild and moderately severe Alzheimer’s disease. The symptoms include increasing memory loss, confusion and behavioural changes. As a result, sufferers of Alzheimer’s disease find it more and more difficult to carry out their normal daily activities.
Donepezil/Genepharm is for use in adult patients only.

Composition
Polacrilin Potassium, Microcrystalline cellulose, Lactose monohydrate (Spray Dried), Monosodium citrate anhydrous, Aspartame (E951), Croscarmellose sodium, Silica colloidal anhydrous, Magnesium Stearate, Hydrochloric acid for pH adjustments and purified water.
Indications
Donepezil/Genepharm (donepezil hydrochloride) belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil increases the levels of a substance (acetylcholine) in the brain involved in memory function by slowing down the breakdown of acetylcholine.
It is used to treat the symptoms of dementia in people diagnosed as having mild and moderately severe Alzheimer’s disease. The symptoms include increasing memory loss, confusion and behavioural changes. As a result, sufferers of Alzheimer’s disease find it more and more difficult to carry out their normal daily activities.
Donepezil/Genepharm is for use in adult patients only.

Composition:
Active ingredient: ACETYLCYSTEINE
Excipients:
Saccharin sodium, Glycine, Sodium citrate, Methyl-p-hydroxybenzoate sodium salt E 215, Glucose anhydrous, Orange flavour in powder, B. Carotene 1% cws, Water.

Concentration in Active Substance:
Each teaspoon (5 ml) of the suspension of 200mg/5ml that has been diluted according to the instructions contains 200mg of ACETYLCYSTEINE.

Composition: Acetylcysteine

Indication : For the liquefaction of bronchial excretions in acute and chronic broncho
– pulmonary conditions (bronchitis , emphysema,tranchiobronchitis ,chronic asthmatic bronchitis )when deemed necessary during acute outbreaks of bronchitis , an appropriate antibiotic should  be administered.

Composition:Omeprazole

Indication :
-Gastric ulcer
-Duodenal ulcer
-Esophagitis due to gastro eosophageal regurgitation
-Prevention of gastric acid ingestion during and after general anesthesia in combination with the usual recommended treatment .
-Zollinger –ellison syndrome
-Healing from Helicobacter Pilori in duodenal and gastric ulcer
-Prevention relapse in patients with duodenal and gastric ulcer and severe esophagitis that were poorly responsive to customary medical treatment